Pain treated by: Ginger, Cinnamon, Vitamin D, Omega-3 etc.
Natural pain relief: comparing the evidence
Claude AI - Sept 2026
Cinnamon, ginger, vitamin D, magnesium, curcumin and omega-3 compared using meta-analyses of randomized controlled trials. Each substance has its best evidence in a different kind of pain, so results are grouped by pain type.
At a glance
| Substance | Menstrual pain | Osteoarthritis | Rheumatoid arthritis | Chronic pain (mixed) | After surgery | Muscle cramps |
|---|---|---|---|---|---|---|
| Cinnamon | + | – | – | – | – | – |
| Ginger | + | + (modest) | – | – | – | – |
| Vitamin D | ++ | – | – | ± (mixed) | – | – |
| Magnesium | – | – | – | – | + (IV) | 0 (older adults) |
| Curcumin | – | ++ | – | – | – | – |
| Omega-3 | + (older data) | 0 | ++ | ++ | – | – |
++ consistent benefit of about 1 point or more on a 0–10 scale, or a moderate effect size
+ benefit found, but small effect or limited trials
± conflicting results
0 no meaningful benefit found
– not covered by the meta-analyses cited here
Detailed comparison
| Substance | Pain type | Key pooled result | Trials / people | Evidence quality | Caveats | Source |
|---|---|---|---|---|---|---|
| Cinnamon | Primary dysmenorrhea | Pain lower than placebo (weighted mean difference about 1.8 points) | 9 RCTs, 647 (cinnamon, fennel and ginger combined) | Low to moderate | Few small trials; cassia cinnamon contains coumarin | Xu 2020 |
| Ginger | Osteoarthritis (knee, hip) | Pain SMD −0.30; disability SMD −0.22 | 5 RCTs, 593 | Moderate | Modest effect; dropouts about twice placebo | Bartels 2015 |
| Ginger | Primary dysmenorrhea | Pain relief greater than placebo | Within the 9 RCTs above | Low to moderate | Pooled with cinnamon and fennel trials | Xu 2020 |
| Vitamin D | Dysmenorrhea | Mean difference −1.64 on 0–10 scale | 11 RCTs, 687 | Moderate | High heterogeneity; helped primary, not secondary, dysmenorrhea | 2024 meta-analysis |
| Vitamin D | Primary dysmenorrhea | SMD −1.40; benefit when average weekly dose was over 50,000 IU | 8 RCTs, 695 | Moderate | Mostly short trials | 2023 meta-analysis |
| Vitamin D | Chronic pain (mixed) | Greater decrease in pain score than placebo | 8 RCTs, about 2,450 | Low to moderate | Condition-specific trials (e.g. fibromyalgia) small and inconsistent; large population trials enrolled mostly non-deficient people (D-Health) | Wu 2016 |
| Magnesium (IV) | After surgery | Early pain −0.90; 24-hour pain −0.59; opioid use −6.3 mg morphine equivalent | 22 RCTs, 1,750 | Very low to moderate | Very high heterogeneity; hospital use only | 2026 meta-analysis |
| Magnesium (oral) | Leg and muscle cramps | Unlikely to give meaningful benefit to older adults; conflicting in pregnancy | 11 RCTs, 735 | Moderate (for no benefit in older adults) | Diarrhea and nausea common | Cochrane 2020 |
| Curcumin | Knee osteoarthritis | VAS pain WMD −1.77 vs placebo | 15 RCTs, 1,670 | Moderate | Curcuminoids alone; absorption varies by formulation | Feng 2022 |
| Curcumin | Knee osteoarthritis | VAS pain MD −1.63 vs placebo; fewer adverse reactions than NSAIDs | 23 studies, 2,175 | Moderate | Network meta-analysis (indirect comparisons) | Zhao 2024 |
| Omega-3 | Chronic pain (mixed) | SMD −0.55; grew from −0.27 at 1 month to −0.83 at 6 months | Multiple RCTs | Moderate | High heterogeneity; helped RA and migraine but not osteoarthritis; doses of 1.35 g/day or less worked at least as well | 2025 meta-analysis |
| Omega-3 | Rheumatoid arthritis | NSAID use reduced (SMD −0.52) at more than 2.7 g/day for over 3 months | 10 RCTs, 370 | Moderate | Small trials | Lee 2012 |
| Omega-3 | Inflammatory joint pain, dysmenorrhea | Joint pain improved after at least 3 months | 17 RCTs | Low | Older review with reporting limitations | Goldberg 2007 |
How to read the numbers
On a 0–10 pain scale, a change of about 1 point is often taken as the smallest difference patients notice. By that measure, vitamin D for menstrual pain and curcumin for knee osteoarthritis are clearly in a meaningful range. IV magnesium after surgery is borderline, and ginger for osteoarthritis is small.
SMD (standardized mean difference) results cannot be compared directly with 0–10 point differences. As a rough guide, an SMD of 0.2 is small, 0.5 moderate and 0.8 large.
Summary
- Menstrual pain is the one condition where vitamin D, ginger, cinnamon and omega-3 all have supportive meta-analyses. Vitamin D has the strongest of these, with dose-response data.
- For osteoarthritis, curcumin shows larger effects than ginger. Omega-3 did not help osteoarthritis in the most recent analysis.
- Omega-3 is best supported for rheumatoid arthritis and mixed chronic pain, with benefit growing over months.
- Vitamin D's effect on chronic pain appears to depend on baseline vitamin D status, which most large population trials did not select for.
- The best magnesium evidence is for IV use during surgery. Oral magnesium did not prevent cramps in older adults.
Here's how the four compare, drawing mainly on meta-analyses of randomized trials. The strongest findings come from different kinds of pain for each substance, so the table is organized by the pain type with the best evidence.
| Substance | Pain type with best evidence | Key pooled result | Evidence quality | Caveats | Source |
|---|---|---|---|---|---|
| Cinnamon | Primary dysmenorrhea | Pain intensity clearly lower than placebo (weighted mean difference ≈1.8 points) | Low to moderate; few small trials | Little data on other pain types; cassia cinnamon contains coumarin | [Xu 2020 MA] |
| Ginger | Osteoarthritis (knee/hip) | SMD −0.30 for pain, −0.22 for disability (5 RCTs, 593 pts) | Moderate | Modest effect; dropouts about 2× placebo | [Bartels 2015 MA] |
| Ginger | Primary dysmenorrhea | Significant pain relief vs placebo | Low to moderate | Pooled with cinnamon/fennel trials | [Xu 2020 MA] |
| Vitamin D | Dysmenorrhea | MD −1.64 on a 0–10 scale (11 RCTs, 687 pts) | Moderate | High heterogeneity; helped primary but not secondary dysmenorrhea | [2024 MA with TSA] |
| Vitamin D | Dysmenorrhea (dose) | SMD −1.40 (8 RCTs, 695 pts); benefit when weekly dose exceeded 50,000 IU | Moderate | Mostly short trials | [2023 MA] |
| Vitamin D | Chronic pain (mixed) | Greater drop in pain score vs placebo (8 RCTs, ~2,450 pts) | Low to moderate | Condition-specific trials (e.g. fibromyalgia) mostly small and inconsistent | [Wu 2016 MA] |
| Magnesium (IV) | Post-surgical pain | Early pain −0.90, 24 h pain −0.59, opioid use −6.3 mg morphine equiv. (1,750 pts) | Very low to moderate | Very high heterogeneity; hospital use only | [2026 MA] |
| Magnesium (oral) | Leg/muscle cramps | Unlikely to help older adults; conflicting in pregnancy | Moderate (for no benefit in elderly) | Diarrhea and nausea common | [Cochrane 2020] |
How to read the numbers. On a 0–10 pain scale, a change of about 1 point is often treated as the smallest difference patients notice. By that yardstick, vitamin D and cinnamon for menstrual pain are in a clinically meaningful range. IV magnesium right after surgery is borderline. Ginger for arthritis (an SMD of 0.3) is a small effect, roughly comparable to what's reported for many oral NSAID alternatives. Results reported as SMD and as MD can't be compared directly.
Vitamin D details. In one dysmenorrhea meta-analysis, pain lessened when the average weekly dose was over 50,000 IU, regardless of whether it was given for more or less than 70 days and at any dose interval. For chronic pain, the picture is less settled. Randomized trials in conditions like fibromyalgia have generally shown no benefit, but most were limited in size and quality. The large D-Health trial randomized 21,315 people aged 60–84 to 60,000 IU vitamin D3 monthly or placebo, measuring pain at 1, 2 and 5 years [D-Health pain analysis]. Like most population trials, it enrolled mostly non-deficient people, which you'd expect to weaken any effect.
Magnesium details. Perioperative magnesium works as an NMDA-antagonist adjunct, but an earlier umbrella review concluded that despite mostly positive results, heterogeneity was substantial for every outcome, limiting confidence in the benefit [Umbrella review 2021]. For cramps, Cochrane found that minor side effects, mostly diarrhea and nausea, affected roughly 11% to 37% of participants [Cochrane summary]. Oral magnesium is also a guideline-level option for migraine prevention, which I didn't include in the table.
Overall. Menstrual pain is the one condition where three of the four (cinnamon, ginger, vitamin D) have supportive meta-analyses. Ginger is the best-established for osteoarthritis. Vitamin D's broader chronic-pain effect likely depends on baseline status. The most rigorous magnesium evidence is for IV use in surgery rather than oral supplements.
Related in VitaminDWiki
- Dr. Greger's upcoming book "How Not to Hurt"
discusses cinnamon and ginger - Pain - chronic
- 15,000 US deaths per year from NSAIDs (0 deaths from Vitamin D)
- 24% of Americans had chronic pain as of 2023 (Vitamin D fights most chronic pain)
- Magnesium reduces pain - many studies
Vitamin D (sublingual nanoemulsion in hours, loading dose in a week )
- A drug that could reduce all these health problems is worth a Trillion dollars - video Holick
- Vitamin D Can Reduce the Pain (and chance) of Dying
- Pain sources vs. Vitamin D
- Fibromyalgia pain, fatigue, etc. reduced by 50,000 IU of Vitamin D for 12 weeks
- Vitamin D interplay with pain
- Widespread pain, arthritis pain and muscle pain are associated with low vitamin D – meta-analysis
- Chronic Pain reported 38 percent less often if supplemented with Vitamin D – meta-analysis
- 7 improvements in lives of veterans with chronic pain with 50,000 IU vitamin D weekly
- Vitamin D receptor is activated somewhat by ginger, thyme, coriander, and lemongrass
- Vitamin D may influence pain intensity – review
- Complex Regional Pain Syndrome 14X more likely if low Vitamin D
- Overview Pain and Vitamin D
- Growing pains associated with low Vitamin D - many studies
- Growing pains reduced in 91% of children with a single dose of Vitamin D
I had frequent "growing pains" as a child. One of my many symptoms of low vitamin D - Discover the Pain of Vitamin D Deficiency
- Half as many headaches if high Vitamin D level (age 6-19)